1. What Is the AI in Pathology Market?
The AI in Pathology Market covers computational pathology systems applying deep learning to whole-slide image analysis for tissue diagnosis, biomarker quantification, and pathological grading. AI pathology encompasses tumour detection algorithms, immune cell density scoring, spatial transcriptomics integration, and AI-assisted workflow routing in anatomical pathology laboratories. Market dynamics reflect whole-slide scanner adoption enabling digital pathology conversion, oncology biomarker scoring demand exceeding pathologist capacity, and pharma clinical trial tissue analysis creating commercial demand.
2. AI in Pathology Market Size & Forecast
3. Emerging Technologies
- AI-powered tumour infiltrating lymphocyte scoring automating immune cell density quantification from H&E stained tissue sections are advancing as immunotherapy response prediction tools. Growing pharma adoption is driven by predictive biomarker needs for immune checkpoint inhibitor trials.
- Digital pathology workflow management AI routing urgent oncology cases to pathologist priority queues are advancing as laboratory efficiency tools. Growing adoption at high-volume cancer centres is driven by reporting turnaround time requirements.
- AI tools detecting rare or subtle histological features including signet ring cells, perineural invasion, and lymphovascular invasion are advancing as pathologist aid tools. Growing deployment at community hospitals is driven by rare feature detection capability exceeding general pathologist training.
- Foundation models for pathology pre-trained on billion-pixel whole-slide image datasets are advancing as general-purpose tissue AI supporting multiple diagnostic applications. Growing research adoption is driven by transfer learning efficiency over task-specific models.
Comparable technologies are influencing adjacent market segments in similar ways. Read more in our AI In Radiology Market.
4. Key Market Opportunity
The highest-value opportunity in the AI in Pathology Market is the oncology tissue biomarker scoring sub-market, where pharmaceutical companies conducting companion diagnostic validation and clinical trial tissue analysis create sustained high-margin revenue for AI pathology vendors. Hospital pathology laboratory digitalisation combined with AI workflow routing creates a recurring software revenue opportunity as WSI scanner installation enables AI integration. Precision oncology molecular-morphological integration creating AI-based predictive signatures beyond traditional biomarkers creates a advanced diagnostic product category. Asia Pacific pathology AI adoption creates geographic expansion opportunity as Chinese and Japanese academic hospitals digitise pathology workflows.
5. Top Companies in the AI in Pathology Market
The following organisations hold leading positions in the AI in Pathology Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Paige AI
- PathAI
- Visiopharm
- Halo AI (Indica Labs)
- Proscia
- QuPath (academic)
- 10x Genomics (Xenium)
- Tempus
- Aiforia
- Nucleai
6. Market Segmentation
The AI in Pathology Market is analysed across 4 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Application | Tumour DetectionBiomarker ScoringGrading and StagingSpatial AnalysisWorkflow Routing |
| By Tissue Type | OncologyDermatologyNephrologyGynaecologyNeuropathology |
| By End User | Hospital Pathology LabsReference LabsPharma CROsAcademic Medical Centres |
| By Geography | North AmericaEuropeAsia PacificLatin AmericaMiddle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the AI in Pathology Market trajectory over the forecast period:
Paige AI Achieves FDA Breakthrough Device Designation for Prostate Cancer Detection in Pathology.Paige Prostate, FDA-cleared in 2021 and expanded to 20 cancer types by 2024, is deployed at Memorial Sloan Kettering and 300 partner pathology laboratories. Paige's partnership with Microsoft Azure deploying whole-slide AI inference at cloud scale demonstrates the enterprise infrastructure model for commercial computational pathology deployment.
Pharma AI Pathology Biomarker Scoring Is Replacing Manual IHC Quantification in Clinical Trials.AstraZeneca and Roche deploying Visiopharm AI biomarker scoring across Phase 2 and Phase 3 trials in 2024 reduced inter-pathologist variability in PD-L1 and HER2 scoring from 18 to 4 percent. Pharma clinical trial use of AI pathology scoring reducing protocol amendment risk and analysis cost is establishing the pharmaceutical industry as the highest-margin AI pathology customer segment.
Spatial Transcriptomics AI Is Integrating Gene Expression Data With Tissue Architecture Analysis.The Xenium platform from 10x Genomics, combined with Vizgen AI analysis at 60 academic centres in 2024, mapped spatial gene expression at single-cell resolution within tissue sections. Integration of spatial omics data with morphological AI pathology analysis is creating a high-complexity precision oncology data product category commanding premium pricing.
For related market intelligence, see the AI In Medical Imaging Market.
8. Segmental Analysis
By application, the Tumour Detection and Grading segment dominated the AI in Pathology Market in 2025. Representing the largest revenue category as oncology pathology AI achieves the broadest FDA clearance and pharma adoption for tissue diagnosis support. The Biomarker Quantification and Scoring segment is the fastest-growing category, advancing as pharma companion diagnostic and clinical trial biomarker standardisation drives commercial adoption.
By end user, the Pharma CRO segment is registering the highest growth rate in 2025, while Hospital Pathology Labs dominate cumulative installed base.
By tissue type, the Oncology segment dominated the AI in Pathology Market in 2025, as tumour grading, biomarker scoring, and companion diagnostic integration generate the largest computational pathology revenue. Dermatology is the fastest-growing tissue category, driven by skin lesion AI models enabling non-specialist pathology review and teledermatology diagnostic automation.
9. Regional Analysis
Regional demand patterns across the AI in Pathology Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America accounted for the largest share of the AI in Pathology Market in 2025, holding 44.6% of the global market. Oncology centres, academic medical centres, and reference laboratories are deploying AI pathology platforms to improve tissue biomarker quantification, tumour grading consistency, and rare pathology detection accuracy. FDA regulatory clarity for AI-based in vitro diagnostic devices and increasing adoption of whole slide imaging are encouraging pathology departments to invest in AI analysis capabilities. Rising cancer diagnosis volumes, growing companion diagnostic requirements, and demand for remote pathology consultation are generating strong adoption of computational pathology platforms.
Highest CAGR Region
Asia Pacific is expected to register the highest CAGR of 29.29% during the forecast period. The rapid expansion of cancer screening programmes and increasing pathology laboratory investment across China, India, and South Korea are creating institutional demand for AI-powered slide analysis platforms to scale diagnostic throughput. Rising demand for pathology services in understaffed regional hospitals and increasing adoption of telepathology consultation networks are generating deployment of AI-assisted analysis tools. Expanding pharmaceutical clinical trial activity requiring centralised pathology review and growing biomarker testing volumes are accelerating AI pathology adoption.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology adoption trends and innovation tracking
- • Custom company profiling and benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country Trade Analysis
- • Country-level opportunity mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • List of Raw Material Suppliers
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The AI in Pathology Market was valued at USD 817.20 Mn in 2025 and is projected to reach USD 5,958.40 Mn by 2034, growing at a CAGR of 24.7% over the 2026–2034 forecast period.
The AI in Pathology Market is projected to grow at a CAGR of 24.7% from 2026 to 2034.
North America accounted for the largest share of the AI in Pathology Market in 2025, holding 44.6% of the global market.
The leading companies in the AI in Pathology Market include Paige AI, PathAI, Visiopharm, Halo AI (Indica Labs), Proscia, QuPath (academic), 10x Genomics (Xenium), Tempus, Aiforia, Nucleai.
Paige ai achieves fda breakthrough device designation for prostate cancer detection in pathology.
By application, the Tumour Detection and Grading segment dominated the AI in Pathology Market in 2025.
How to Order
Purchasing a TrendX Insights report is straightforward. Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.
This is the price of the syndicated report. Any custom inclusions beyond the Table of Contents will be scoped and priced separately. For the full list of what is covered in the syndicated report, refer to the Table of Contents tab.
A curated, condensed version of this report for students, researchers, and academic institutions. Ideal for thesis work, dissertations, and academic projects. Delivered as PDF to your institutional email.
Valid student ID or institutional email required. For educational and non-commercial use only.